» Articles » PMID: 30886525

A Review of MicroRNA Biomarkers in Traumatic Brain Injury

Overview
Journal J Exp Neurosci
Publisher Sage Publications
Specialty Neurology
Date 2019 Mar 20
PMID 30886525
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

There is growing public concern surrounding traumatic brain injury (TBI). TBI can cause significant morbidity, and the long-term sequelae are poorly understood. TBI diagnosis and management rely on patient-reported symptoms and subjective clinical assessment. There are no biologic tools to detect mild TBI or to track brain recovery. Emerging evidence suggests that microRNAs (miRNAs) may provide information about the injured brain. These tiny epigenetic molecules are expressed throughout the body. However, they are particularly important in neurons, can cross the blood-brain barrier, and are securely transported from cell to cell, where they regulate gene expression. miRNA levels may identify patients with TBI and predict symptom duration. This review synthesizes miRNA findings from 14 human studies. We distill more than 291 miRNAs to 17 biomarker candidates that overlap across multiple studies and multiple biofluids. The goal of this review is to establish a collective understanding of miRNA biology in TBI and identify clinical priorities for future investigations of this promising biomarker.

Citing Articles

Aminophylline targets miR-128-3p/Slc7a11 axis to attenuate neuronal ferroptosis after traumatic brain injury.

Manrui L, Xu Y, Liu J, Zhang X, Yuan R, Sun Y Cell Mol Life Sci. 2025; 82(1):87.

PMID: 39985589 PMC: 11846823. DOI: 10.1007/s00018-025-05601-3.


Efficacy of biomarkers and imaging techniques for the diagnosis of traumatic brain injury: challenges and opportunities.

Duerksen J, Lopez R, Tappia P, Ramjiawan B, Mansouri B Mol Cell Biochem. 2024; .

PMID: 39656395 DOI: 10.1007/s11010-024-05176-w.


Exploring New and Promising Genetic Biomarkers for Evaluating Traumatic Brain Injuries: A Case-Control Study.

Rabou Y, Zayed A, Fahim S, Abdelgwad M, Fiki A, Fayed N Neurochem Res. 2024; 50(1):48.

PMID: 39641810 PMC: 11624226. DOI: 10.1007/s11064-024-04292-9.


Identification of a New Role of miR-199a-5p as Factor Implied in Neuronal Damage: Decreasing the Expression of Its Target X-Linked Anti-Apoptotic Protein (XIAP) After SCI.

Munoz-Galdeano T, Reigada D, Soto A, Barreda-Manso M, Ruiz-Amezcua P, Nieto-Diaz M Int J Mol Sci. 2024; 25(22).

PMID: 39596440 PMC: 11594351. DOI: 10.3390/ijms252212374.


Traumatic Brain Injury as a Public Health Issue: Epidemiology, Prognostic Factors and Useful Data from Forensic Practice.

Karaboue M, Ministeri F, Sessa F, Nannola C, Chisari M, Cocimano G Healthcare (Basel). 2024; 12(22).

PMID: 39595464 PMC: 11593823. DOI: 10.3390/healthcare12222266.


References
1.
Bazarian J, Wong T, Harris M, Leahey N, Mookerjee S, Dombovy M . Epidemiology and predictors of post-concussive syndrome after minor head injury in an emergency population. Brain Inj. 1999; 13(3):173-89. DOI: 10.1080/026990599121692. View

2.
Howell B, Herrick T, Cooper J . Reelin-induced tyrosine [corrected] phosphorylation of disabled 1 during neuronal positioning. Genes Dev. 1999; 13(6):643-8. PMC: 316552. DOI: 10.1101/gad.13.6.643. View

3.
Tyler B, Jansen K, McCormick D, Douglas C, Boules M, Stewart J . Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression. Proc Natl Acad Sci U S A. 1999; 96(12):7053-8. PMC: 22053. DOI: 10.1073/pnas.96.12.7053. View

4.
Cano A, Perez-Moreno M, Rodrigo I, Locascio A, Blanco M, del Barrio M . The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000; 2(2):76-83. DOI: 10.1038/35000025. View

5.
Fatemi S, Earle J, McMenomy T . Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry. 2000; 5(6):654-63, 571. DOI: 10.1038/sj.mp.4000783. View